<DOC>
	<DOC>NCT00289848</DOC>
	<brief_summary>This is a clinical study to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients have Type 2 Diabetes Mellitus and have laboratory results that are within the values established by the study such as an Hemoglobin A1c (HbA1c) &gt;=7.5% and &lt;=11% and a Fasting Plasma Glucose (FPG) &gt;=130 mg/dL and &lt;=280 mg/dL Exclusion Criteria : Patients have Type 1 Diabetes Mellitus or required insulin therapy within the past 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>